Market Research Logo

Genentech Inc - Strategic SWOT Analysis Review

Genentech Inc - Strategic SWOT Analysis Review

Genentech Inc - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology, metabolism, primary care, neurology, virology, hematology and specialty care. It has pipeline candidates in oncology, immunology, neuroscience, metabolism, infectious disease and ophthalmology. The company has research and manufacturing facilities in Vacaville, South San Francisco and Oceanside, California. Genentech is headquartered in South San Francisco, California, the US.

Genentech Inc Key Recent Developments

Jul 19,2018: Genentech to present new data demonstrating the breadth and depth of its alzheimer’s program at the upcoming Alzheimer's Association International Conference (AAIC)
Jul 16,2018: Yardi's Matt Eggers Joins Board Of Directors Of Institute For Market Transformation
Jun 06,2018: Microbiotica Enters into Microbiome Collaboration with Genentech
May 14,2018: Pivotal Study Validates Real-World Mortality Endpoint for Oncology Research
May 09,2018: Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Genentech Inc - Key Facts
Genentech Inc - Key Employees
Genentech Inc - Key Employee Biographies
Genentech Inc - Major Products and Services
Genentech Inc - History
Genentech Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Genentech Inc - Business Description
Genentech Inc - SWOT Analysis
SWOT Analysis - Overview
Genentech Inc - Strengths
Genentech Inc - Weaknesses
Genentech Inc - Opportunities
Genentech Inc - Threats
Genentech Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Genentech Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jul 19, 2018: Genentech to present new data demonstrating the breadth and depth of its alzheimer’s program at the upcoming Alzheimer's Association International Conference (AAIC)
Jul 16, 2018: Yardi's Matt Eggers Joins Board Of Directors Of Institute For Market Transformation
Jun 06, 2018: Microbiotica Enters into Microbiome Collaboration with Genentech
May 14, 2018: Pivotal Study Validates Real-World Mortality Endpoint for Oncology Research
May 09, 2018: Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech
May 07, 2018: Genentech to Present New Data From Its Industry-Leading Oncology Portfolio at The 2018 American Society of Clinical Oncology Annual Meeting
Mar 13, 2018: New Approach to Standardize and Improve Inhibitor Testing for People with Hemophilia A
Feb 05, 2018: Inside Rx Provides Savings on Influenza Medications
Dec 12, 2017: How Immunotherapy of Cancer May Create Novel Clinical Utilities for HLA Typing
Dec 12, 2017: Late-Breaking Clinical Trials Signal New Therapeutic Options for Many Patients in the Near Term
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Genentech Inc, Key Facts
Genentech Inc, Key Employees
Genentech Inc, Key Employee Biographies
Genentech Inc, Major Products and Services
Genentech Inc, History
Genentech Inc, Other Locations
Genentech Inc, Key Competitors
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Genentech Inc, Recent Deals Summary
List of Figures
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Genentech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report